Product Information

SELEGILINE HCL 5 MG TABLET is a generic product labeled by i3 Pharmaceuticals, LLC, priced at $0.7777 per EA under NDC 72319000602. Its NADAC has been published 219 times since Apr 20, 2022.

SELEGILINE HCL 5 MG TABLET

Selegiline Hydrochloride
$0.7777per EA

Strength

5 mg/1

NDC

72319000602

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

SELEGILINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074672

On Market Since

12/15/2021

Pharmacological Classes

Monoamine Oxidase Inhibitor
Monoamine Oxidase Inhibitors
Monoamine Oxidase Type B Inhibitor
Monoamine Oxidase-B Inhibitors

Price Statistics

The NADAC for SELEGILINE HCL 5 MG TABLET has been published 219 times since Apr 20, 2022, and over the history we have for it it has declined 22.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7777 per EA
All-time high$1.0975 (Aug 10, 2022)
All-time low$0.6101 (Jul 17, 2024)
52-week high$0.8981
52-week low$0.6895
Median price$0.8231
Average price$0.8280
Largest weekly change+33.5% (May 17, 2023)
Weeks tracked219
Tracking sinceApr 20, 2022

Price History

1W

0.0%

1M

+2.6%

3M

+9.3%

6M

+9.6%

1Y

-10.4%

3Y

-12.7%

5Y

N/A

All

-22.9%

Generic Alternatives

The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of SELEGILINE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SELEGILINE HCL 5 MG TABLET, manufactured by i3 Pharmaceuticals, LLC, is $0.7777 per EA (NDC 72319000602), effective Jun 24, 2026.

How has the price of SELEGILINE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for SELEGILINE HCL 5 MG TABLET has declined 22.9%. It has been tracked across 219 weekly CMS publications since Apr 20, 2022.

What are the highest and lowest recorded NADAC prices for SELEGILINE HCL 5 MG TABLET?

Since Apr 20, 2022, the NADAC for SELEGILINE HCL 5 MG TABLET has ranged from a low of $0.6101 (Jul 17, 2024) to a high of $1.0975 (Aug 10, 2022), with a median of $0.8231 per EA.

Are there cheaper alternatives to SELEGILINE HCL 5 MG TABLET?

Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, SELEGILINE HCL 5 MG TABLET, is $0.6101 per EA — about 22% below SELEGILINE HCL 5 MG TABLET.

Who manufactures SELEGILINE HCL 5 MG TABLET?

SELEGILINE HCL 5 MG TABLET (NDC 72319000602) is labeled by i3 Pharmaceuticals, LLC, and CMS classifies it as a generic product.